TD Cowen Reiterates Buy Rating on Arcutis Biotherapeutics Inc. (ARQT)

August 15, 2024 9:21 AM

TD Cowen analyst Ken Cacciatore reiterated a Buy rating and $20.00 price target on Arcutis Biotherapeutics Inc. (NASDAQ: ARQT).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found